Shares of Anpario plc (LON:ANP - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of GBX 516.51 and traded as high as GBX 530. Anpario shares last traded at GBX 530, with a volume of 18,008 shares changing hands.
Analysts Set New Price Targets
Several analysts have issued reports on ANP shares. Canaccord Genuity Group upped their price target on shares of Anpario from GBX 570 to GBX 600 and gave the company a "buy" rating in a research report on Friday, September 11th. Shore Capital Group reissued a "house stock" rating on shares of Anpario in a research note on Monday, August 17th. One analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy" and a consensus target price of GBX 600.
Read Our Latest Report on Anpario
Anpario Stock Up 0.6%
The company's fifty day simple moving average is GBX 507.10 and its 200 day simple moving average is GBX 516.51. The company has a quick ratio of 5.16, a current ratio of 6.29 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of £86.10 million, a PE ratio of 13.43 and a beta of 1.05.
Anpario (LON:ANP - Get Free Report) last announced its earnings results on Wednesday, September 9th. The company reported GBX 22.45 earnings per share (EPS) for the quarter. Anpario had a return on equity of 17.05% and a net margin of 14.53%. Analysts anticipate that Anpario plc will post 23.58 earnings per share for the current fiscal year.
Anpario Company Profile
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.